Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

Article metrics

Correction to: Blood Cancer Journal (2014) 4, e182; doi:10.1038/bcj.2014.1; published online 21 February 2014

Since the publication of this article, the authors have identified an error concerning one of the author affiliation addresses. KC Anderson was incorrectly affiliated to the following address: ‘Merck & Co. Inc., Whitehouse Station, NJ, USA’. The correct address details are shown here.

The article has also been rectified, and now carries the correct information.

The Authors would like to apologise for any inconvenience this may have caused.

Author information

Correspondence to D S Siegel.

Additional information

The online version of the original article can be found at 10.1038/bcj.2014.1

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Siegel, D., Richardson, P., Dimopoulos, M. et al. Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma. Blood Cancer Journal 4, e202 (2014) doi:10.1038/bcj.2014.23

Download citation

Further reading